Company JD Health International Inc. Other OTC
Equities
JDHIF
KYG5074A1004
Drug Retailers
Business Summary
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical and Healthcare
85.3
%
| 46,942 | 86.4 % | 50,446 | 85.3 % | +7.47% |
Marketplace, Advertising and Other
14.7
%
| 7,407 | 13.6 % | 8,704 | 14.7 % | +17.51% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 54,348 | 100.0 % | 59,150 | 100.0 % | +8.84% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
En Lin Jin
CEO | Chief Executive Officer | 44 | 21-09-05 |
Deng Hui
DFI | Director of Finance/CFO | 38 | 23-05-10 |
Ming King Chiu
SEC | Corporate Secretary | 47 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ying Wu
BRD | Director/Board Member | 65 | 22-04-06 |
Qiang Dong Liu
CHM | Chairman | 52 | 20-09-13 |
Qing Qing Yi
BRD | Director/Board Member | 52 | 20-08-20 |
Xing Yao Chen
BRD | Director/Board Member | 50 | - |
Ling Li
BRD | Director/Board Member | 63 | - |
Ji Yu Zhang
BRD | Director/Board Member | - | 21-03-28 |
En Lin Jin
CEO | Chief Executive Officer | 44 | 21-09-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,189,465,111 | 1,030,975,454 ( 32.32 %) | 0 | 32.32 % |
Company contact information
JD Health International, Inc.
8th Floor, Building C No. 18 Kechuang 11 Street
101111, Beijing
+
Group companies
Name | Category and Sector |
---|---|
JD Health (HK) Ltd.
|
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-37.88% | 13.99B | |
+12.54% | 6.29B | |
-11.17% | 5.88B | |
+75.00% | 4.96B | |
-2.92% | 4.54B | |
-9.20% | 3.74B | |
-19.40% | 3.16B | |
-12.15% | 2.85B | |
-12.99% | 2.53B |